Previous 10 | Next 10 |
Gainers: Doximity (NYSE:DOCS) +20%. Aptevo Therapeutics (NASDAQ:APVO) +17%. Biofrontera (NASDAQ:BFRA) +14%. Karyopharm Therapeutics (NASDAQ:KPTI) +14%. Teva Pharmaceutical (NYSE:TEVA) +9%. Losers: Varex Imaging (NASDAQ:VREX) -11%. BioCardia (NASDAQ...
Earnings news took center stage in Wednesday's pre-market action. Chipotle (NYSE:CMG) and Doximity (NYSE:DOCS) both scored investor interest following the release of strong earnings and guidance. On the other side of the spectrum, Lyft (NASDAQ:LYFT) and CVS Health (NYSE:CVS) failed to impress...
Doximity, Inc. (DOCS) Q3 2022 Earnings Conference Call February 08, 2022, 05:00 PM ET Company Participants Perry Gold - Head, IR Jeff Tangney - Co-Founder and CEO Anna Bryson - CFO Nate Gross - Co-Founder and Chief Strategy Officer Conference Call Participants Stephanie Davis - SVB Leerink Ry...
Doximity (NYSE:DOCS) shares have climbed ~7% in the post-market on Tuesday after the company’s Q3 financials for fiscal 2022 stood well ahead of expectations. Revenue for the quarter surged ~67% YoY to $97.9M beating Street forecasts by as much as ~$11.6M. Meanwhile, the...
Doximity to Acquire Amion, Leader in Physician Scheduling Amion manages nearly 200k physician schedulesat thousands of hospitals including 18 of the top 20 PR Newswire SAN FRANCISCO , Feb. 8, 2022 /PRNewswire/ -- Doximity, Inc. (NYSE: DOCS), the leading digit...
Doximity press release (NYSE:DOCS): FQ3 Non-GAAP EPS of $0.29 beats by $0.17. Revenue of $97.88M (+66.7% Y/Y) beats by $11.61M. Shares +6.4%. Q4 Outlook: Revenue between $89.0 million and $90.0 million, Adjusted EBITDA between $34.0 million and $35.0 million. FY Outlook: Revenue bet...
Doximity Announces Fiscal 2022 Third Quarter Financial Results Total revenues of $97.9 million, up 67% year-over-year Net income margin of 57% and adjusted EBITDA margin of 48% PR Newswire SAN FRANCISCO , Feb. 8, 2022 /PRNewswire/ -- Doximity, Inc. (NYSE...
Doximity Dialer is Ranked #1 in the 2022 Best in KLAS report for Telehealth Video Conferencing Platform Doximity Dialer Also Receives Top Grades for Culture, Loyalty, Operations, Product, Relationship, and Value PR Newswire SAN FRANCISCO , Feb. 8, 2022 /PRNew...
AIZ, AMRK, AMX, APPS, ARI, ATGE, ATO, AZTA, BBD, CCK, CMG, CMP, CRSR, DCPH, DOCS, EGP, ENPH, ENTA, FLT, FMC, GAIN, GFS, HIW, HUBG, ICHR, INSP, ISR, JKHY, KREF, LBRT, LYFT, MNDT, NBR, NCR, NEWR, OMC, ONTO, PAYC, PEAK, PSEC, PTON, QGEN, SAVE, STE, SVM, TCS, TRMB, TRVG, TSE, UDR, USNA, VOYA, VRE...
The mini-crash of January has given investors the opportunity to buy some amazing healthcare companies at a discount. First we're going to take a look at Doximity (NYSE: DOCS) , a telehealth powerhouse that is almost 60% off its highs. Next up is Novocure (NASDAQ: NVCR) , a ...
News, Short Squeeze, Breakout and More Instantly...
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Doximity, Inc. (NYSE: DOCS). On August 8, 2023, the Company disclosed disappointing guidance ...
Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal first quarter ended June 30, 2024 after market close on August 8, 2024. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p...
2024-07-10 22:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...